Blood test study to detect stomach cancer spread in the belly
Part of Cancer, Digestive system clinical trials.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 74 when you sign consent.
- You can sign written consent for the study.
- You have a new stomach cancer diagnosis (or strong suspicion) tied to a diagnosis within 42 days around the blood draw.
- You had a laparoscopy with cytology showing either belly lining spread (case group) or no belly lining spread (control group).
- No prior cancer treatment before the blood sample (no surgery/radiation/chemo/other cancer treatment).
- You can provide a blood sample that is sufficient for testing, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
This study is testing a new way to find stomach (gastric) cancer early using a simple blood test. It may help people who have just been diagnosed with stage I, II, or III stomach cancer and have not started treatment yet.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study is testing whether small molecules in your blood (called 'small non-coding RNAs') can help doctors more accurately diagnose stomach cancer. If you have recently been diagnosed, this study will look for those molecules to see if they can be used as a simple blood test in the future.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study tests a new blood test that uses machine learning to find hidden stomach cancer spread (peritoneal metastases) early. It could help people with locally advanced stomach cancer avoid unnecessary surgery.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.